Fig 7.
A. Everolimus versus calcineurin inhibitor; any adverse events up to 1 year after transplantation; B. Everolimus versus calcineurin inhibitor; any serious adverse events up to 1 year after transplantation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.